Scott Helton
Overview
Explore the profile of Scott Helton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
341
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Berardi G, Cucchetti A, Sposito C, Ratti F, Nebbia M, DSouza D, et al.
JHEP Rep
. 2024 Jul;
6(7):101075.
PMID: 38961853
Background & Aims: Metabolic syndrome (MS) is a growing epidemic and a risk factor for the development of hepatocellular carcinoma (HCC). This study investigated the long-term outcomes of liver resection...
2.
Chung C, Stovall S, Biehl S, Rocha F, Wancata L, Helton S, et al.
Am J Surg
. 2024 Apr;
237:115746.
PMID: 38641448
Background: Pancreaticoduodenectomy has been the standard of care for managing duodenal neoplasms, but recent studies show similar overall and disease-specific survival after pancreas-preserving duodenectomy (PPrD) with potentially less morbidity. Methods:...
3.
Eshmuminov D, Aminjonov B, Palm R, Malleo G, Schmocker R, Abdallah R, et al.
Ann Surg Oncol
. 2023 Apr;
30(7):4417-4428.
PMID: 37020094
Background: Pancreatic cancer often presents as locally advanced (LAPC) or borderline resectable (BRPC). Neoadjuvant systemic therapy is recommended as initial treatment. It is currently unclear what chemotherapy should be preferred...
4.
Berardi G, Ivanics T, Sapisochin G, Ratti F, Sposito C, Nebbia M, et al.
Ann Surg
. 2023 Mar;
278(5):e1041-e1047.
PMID: 36994755
Objective: To compare minimally invasive (MILR) and open liver resections (OLRs) for hepatocellular carcinoma (HCC) in patients with metabolic syndrome (MS). Background: Liver resections for HCC on MS are associated...
5.
Berardi G, Ratti F, Sposito C, Nebbia M, DSouza D, Pascual F, et al.
Hepatology
. 2023 Jan;
77(5):1527-1539.
PMID: 36646670
Background: Metabolic syndrome (MS) is rapidly growing as risk factor for HCC. Liver resection for HCC in patients with MS is associated with increased postoperative risks. There are no data...
6.
Giovinazzo F, Soggiu F, Jang J, Versteijne E, van Tienhoven G, Van Eijck C, et al.
Front Oncol
. 2020 Aug;
10:1112.
PMID: 32850319
Non-randomized studies have investigated multi-agent gemcitabine-based neo-adjuvant therapies (GEM-NAT) in borderline resectable pancreatic ductal adenocarcinoma (BR-PDAC). Treatment sequencing and specific elements of neoadjuvant treatment are still under investigation. The present...
7.
Rekman J, Smith P, Bonds M, Coy D, Helton S
Surg Oncol Clin N Am
. 2019 Sep;
28(4):539-572.
PMID: 31472905
The accurate diagnosis of a liver mass can usually be established with a thorough history, examination, laboratory inquiry, and imaging. The necessity of a liver biopsy to determine the nature...
8.
Hyun J, Rose J, Alseidi A, Biehl T, Helton S, Coy D, et al.
J Surg Oncol
. 2019 May;
120(2):262-269.
PMID: 31093997
Background And Objectives: Unlike pancreatic head tumors, little is known about the biological significance of radiographic vessel involvement with pancreatic body/tail adenocarcinoma. We hypothesized radiographic splenic vessel involvement may be...
9.
Barnes J, Duncan D, Helton S, Hutcheson S, Kurundkar D, Logsdon N, et al.
Am J Physiol Lung Cell Mol Physiol
. 2019 May;
317(1):L141-L154.
PMID: 31042083
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive fibrosing interstitial pneumonia that mainly affects the elderly. Several reports have demonstrated that aging is involved in the underlying pathogenic mechanisms of...
10.
Bertens K, Massman 3rd J, Helton S, Garbus S, Mandelson M, Lin B, et al.
J Surg Oncol
. 2018 May;
117(8):1655-1663.
PMID: 29761510
Background And Objectives: Although race and socioeconomic status have been shown to affect outcomes in pancreatic ductal adenocarcinoma (PDAC), the impact of rural residence on the delivery of adjuvant therapy...